Company Description
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States.
The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down.
The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies.
It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities.
FONAR Corporation was founded in 1970 and is based in Melville, New York.
| Country | United States |
| Founded | 1978 |
| IPO Date | Jan 1, 1987 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 561 |
| CEO | Timothy R. Damadian M.D. |
Contact Details
Address: 110 Marcus Dr Melville, New York 11747 United States | |
| Phone | (631) 694-2929 |
| Website | fonar.com |
Stock Details
| Ticker Symbol | FONR |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000355019 |
| CUSIP Number | 344437405 |
| ISIN Number | US3444374058 |
| Employer ID | 11-2464137 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Timothy R. Damadian M.D. | Chairman, President, Chief Executive Officer and Treasurer |
| Luciano B. Bonanni | Chief Operating Officer, Executive Vice President and Acting Principal Financial Officer |
| Claudette J. V. Chan | Secretary and Director |
| Daniel Culver | Director of Communications |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 8, 2024 | DEF 14A | Other definitive proxy statements |
| Feb 15, 2024 | 8-K | Current Report |
| Feb 14, 2024 | 10-Q | Quarterly Report |
| Feb 13, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 15, 2023 | 8-K | Current Report |
| Nov 14, 2023 | 10-Q | Quarterly Report |
| Sep 29, 2023 | 8-K | Current Report |